Nifty
:
26142.10
Sensex
:
85408.70
-35.05 (-0.13%)
-116.14 (-0.14%)
Nifty
Sensex
:
:
26142.10
85408.70
-35.05 (-0.13%)
-116.14 (-0.14%)

Alembic Ltd.

Pharmaceuticals & Drugs - API

Rating :
66/99

BSE: 506235 | NSE: ALEMBICLTD

NSE BSE
101.11
24-Dec-2025
  • Open
  • High
  • Low
  • Previous Close
  •  101.85
  •  102.92
  •  101
  •  101.84
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  178235
  •  18133155.82
  •  137.66
  •  85.46

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,595.04
  • 8.01
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,604.20
  • 2.37%
  • 1.02

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.88%
  • 0.64%
  • 22.29%
  • FII
  • DII
  • Others
  • 1.38%
  • 0.00%
  • 4.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.69
  • 24.72
  • 20.37

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.63
  • 55.13
  • 18.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.32
  • 59.88
  • 21.49

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.17
  • 9.38
  • 9.79

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.18
  • 1.15
  • 1.17

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.09
  • 33.49
  • 20.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Net Sales
55.86
52.91
5.58%
49.75
50.78
-2.03%
60.27
49.04
22.90%
57.92
39.32
47.30%
Expenses
32.62
33.34
-2.16%
30.18
30.38
-0.66%
32.95
24.89
32.38%
31.52
27.64
14.04%
EBITDA
23.24
19.57
18.75%
19.57
20.40
-4.07%
27.32
24.15
13.13%
26.40
11.68
126.03%
EBIDTM
41.60%
36.99%
39.34%
40.17%
45.33%
49.25%
45.58%
29.70%
Other Income
64.92
65.61
-1.05%
3.59
1.96
83.16%
2.96
2.04
45.10%
4.37
2.23
95.96%
Interest
0.56
0.67
-16.42%
0.59
0.49
20.41%
0.62
0.48
29.17%
0.69
0.37
86.49%
Depreciation
2.82
2.68
5.22%
2.79
2.50
11.60%
2.75
1.48
85.81%
2.69
2.66
1.13%
PBT
84.78
81.83
3.61%
19.78
19.37
2.12%
26.91
24.23
11.06%
27.39
10.88
151.75%
Tax
8.72
4.52
92.92%
1.98
1.95
1.54%
3.16
2.94
7.48%
1.30
0.96
35.42%
PAT
76.06
77.31
-1.62%
17.80
17.42
2.18%
23.75
21.29
11.55%
26.09
9.92
163.00%
PATM
136.16%
146.12%
35.78%
34.30%
39.41%
43.41%
45.04%
25.23%
EPS
5.00
4.71
6.16%
2.40
2.17
10.60%
2.67
2.81
-4.98%
2.55
2.39
6.69%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
223.80
221.89
157.49
127.24
78.22
73.52
73.93
123.81
125.30
147.16
127.53
Net Sales Growth
16.53%
40.89%
23.77%
62.67%
6.39%
-0.55%
-40.29%
-1.19%
-14.85%
15.39%
 
Cost Of Goods Sold
65.51
69.17
48.95
41.12
22.62
22.24
12.17
54.07
78.50
96.33
69.67
Gross Profit
158.29
152.72
108.53
86.13
55.60
51.28
61.75
69.74
46.79
50.83
57.86
GP Margin
70.73%
68.83%
68.91%
67.69%
71.08%
69.75%
83.52%
56.33%
37.34%
34.54%
45.37%
Total Expenditure
127.27
128.18
100.62
86.91
64.29
63.09
70.79
105.74
114.22
140.45
121.53
Power & Fuel Cost
-
2.34
1.18
2.02
0.15
0.42
0.91
2.34
1.11
5.46
13.26
% Of Sales
-
1.05%
0.75%
1.59%
0.19%
0.57%
1.23%
1.89%
0.89%
3.71%
10.40%
Employee Cost
-
27.31
23.03
24.04
21.47
22.60
20.79
20.52
19.64
22.83
23.79
% Of Sales
-
12.31%
14.62%
18.89%
27.45%
30.74%
28.12%
16.57%
15.67%
15.51%
18.65%
Manufacturing Exp.
-
11.25
10.92
7.02
8.30
5.91
25.52
20.00
6.08
7.11
5.77
% Of Sales
-
5.07%
6.93%
5.52%
10.61%
8.04%
34.52%
16.15%
4.85%
4.83%
4.52%
General & Admin Exp.
-
12.24
11.85
8.90
9.12
6.63
8.30
7.15
6.80
6.48
5.30
% Of Sales
-
5.52%
7.52%
6.99%
11.66%
9.02%
11.23%
5.77%
5.43%
4.40%
4.16%
Selling & Distn. Exp.
-
1.84
2.19
1.90
0.69
0.92
0.87
0.11
0.34
0.90
2.11
% Of Sales
-
0.83%
1.39%
1.49%
0.88%
1.25%
1.18%
0.09%
0.27%
0.61%
1.65%
Miscellaneous Exp.
-
4.03
2.50
1.90
1.93
4.37
2.23
1.56
1.75
1.33
2.11
% Of Sales
-
1.82%
1.59%
1.49%
2.47%
5.94%
3.02%
1.26%
1.40%
0.90%
1.29%
EBITDA
96.53
93.71
56.87
40.33
13.93
10.43
3.14
18.07
11.08
6.71
6.00
EBITDA Margin
43.13%
42.23%
36.11%
31.70%
17.81%
14.19%
4.25%
14.59%
8.84%
4.56%
4.70%
Other Income
75.84
74.89
54.77
64.26
89.18
10.92
93.54
29.45
37.04
30.97
28.81
Interest
2.46
2.47
1.11
0.47
0.39
0.36
0.29
0.22
0.17
0.16
0.12
Depreciation
11.05
10.63
7.84
6.72
4.86
3.94
3.23
2.63
3.78
5.09
6.14
PBT
158.86
155.50
102.69
97.41
97.86
17.04
93.17
44.67
44.18
32.44
28.55
Tax
15.16
10.93
9.82
6.18
11.66
3.20
0.13
3.59
2.39
-0.86
0.61
Tax Rate
9.54%
7.03%
9.56%
7.12%
11.91%
18.78%
0.14%
8.04%
5.41%
-3.23%
2.41%
PAT
143.70
144.57
92.87
80.62
86.19
13.84
93.03
41.08
41.78
27.49
24.72
PAT before Minority Interest
143.70
144.57
92.87
80.62
86.19
13.84
93.03
41.08
41.78
27.49
24.72
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
64.21%
65.15%
58.97%
63.36%
110.19%
18.82%
125.84%
33.18%
33.34%
18.68%
19.38%
PAT Growth
14.10%
55.67%
15.19%
-6.46%
522.76%
-85.12%
126.46%
-1.68%
51.98%
11.21%
 
EPS
5.60
5.63
3.62
3.14
3.36
0.54
3.62
1.60
1.63
1.07
0.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,338.59
2,185.56
2,078.03
2,496.58
2,297.03
1,418.04
1,208.53
1,085.77
911.43
803.13
Share Capital
51.36
51.36
51.36
51.36
51.36
51.36
51.36
53.41
53.41
53.41
Total Reserves
2,287.23
2,134.21
2,026.68
2,445.23
2,245.67
1,366.69
1,157.17
1,032.37
858.02
749.72
Non-Current Liabilities
53.94
52.89
42.74
67.60
52.52
6.88
8.52
14.15
12.61
14.69
Secured Loans
10.67
7.39
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.44
1.91
1.21
1.10
0.83
0.70
0.72
0.80
0.78
0.64
Current Liabilities
127.59
96.11
89.56
67.76
59.41
45.80
48.80
59.12
68.34
57.68
Trade Payables
28.26
31.02
17.38
19.27
17.81
12.99
24.75
16.42
14.76
16.36
Other Current Liabilities
55.39
33.10
45.05
35.54
30.67
22.07
8.07
31.82
39.20
27.37
Short Term Borrowings
0.00
0.00
0.00
0.00
0.28
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
43.94
31.99
27.13
12.96
10.66
10.74
15.97
10.89
14.38
13.95
Total Liabilities
2,520.12
2,334.56
2,210.33
2,631.94
2,408.96
1,470.72
1,265.85
1,159.04
992.38
875.50
Net Block
135.38
130.59
131.88
133.55
233.55
209.47
186.88
147.46
147.60
146.42
Gross Block
156.66
151.54
151.21
151.21
256.22
228.24
202.45
160.37
158.33
371.75
Accumulated Depreciation
21.28
20.95
19.33
17.66
22.67
18.78
15.57
12.92
10.73
225.34
Non Current Assets
2,298.14
2,191.38
2,032.45
2,488.63
2,306.87
1,307.90
1,167.08
972.32
801.10
706.29
Capital Work in Progress
0.00
1.10
0.13
0.19
37.27
18.69
22.26
31.64
0.16
0.00
Non Current Investment
1,844.95
1,774.65
1,708.16
2,182.01
2,030.58
1,078.88
957.76
792.85
651.28
558.62
Long Term Loans & Adv.
36.22
36.22
1.22
6.54
1.95
0.86
0.17
0.38
2.05
1.25
Other Non Current Assets
8.02
10.64
1.64
2.67
3.52
0.00
0.00
0.00
0.00
0.00
Current Assets
221.99
143.19
177.89
143.32
102.09
162.82
98.77
186.73
191.28
169.21
Current Investments
55.10
11.34
45.40
25.84
16.59
53.71
43.46
119.85
104.76
46.13
Inventories
99.39
92.60
88.61
86.87
54.28
35.41
35.33
32.41
50.61
74.90
Sundry Debtors
29.97
19.76
23.45
15.22
13.81
8.98
13.51
25.29
21.60
27.98
Cash & Bank
4.37
2.47
1.90
1.85
6.57
58.85
2.01
0.84
2.32
2.34
Other Current Assets
33.16
3.92
8.95
3.89
10.84
5.86
4.47
8.35
11.98
17.87
Short Term Loans & Adv.
26.30
13.10
9.57
9.65
8.73
4.38
2.59
6.34
9.88
16.24
Net Current Assets
94.40
47.08
88.32
75.56
42.68
117.03
49.97
127.61
122.94
111.53
Total Assets
2,520.13
2,334.57
2,210.34
2,631.95
2,408.96
1,470.72
1,265.85
1,159.05
992.38
875.50

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
86.37
22.69
38.85
-17.75
-2.18
6.54
21.51
23.58
51.63
9.65
PBT
155.50
102.69
86.80
97.86
17.04
93.17
44.67
44.18
26.63
25.33
Adjustment
-52.98
-42.09
-52.87
-78.66
1.65
-85.70
-20.51
-28.85
-20.86
-16.51
Changes in Working Capital
-0.60
-38.47
11.44
-27.90
-18.64
0.60
1.99
11.89
46.06
1.70
Cash after chg. in Working capital
101.93
22.12
45.37
-8.70
0.05
8.06
26.15
27.22
51.83
10.52
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-15.56
0.57
-6.52
-9.04
-2.23
-1.53
-4.64
-3.64
-0.20
-0.87
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-26.58
25.84
7.30
18.85
-34.87
56.72
71.67
-22.40
-46.69
-4.76
Net Fixed Assets
-4.02
-1.30
0.06
138.27
-42.74
-22.22
-32.70
-33.47
213.26
344.49
Net Investments
-3.03
92.03
223.30
-144.79
-383.89
7.99
70.53
-63.48
-62.37
-141.47
Others
-19.53
-64.89
-216.06
25.37
391.76
70.95
33.84
74.55
-197.58
-207.78
Cash from Financing Activity
-58.34
-48.19
-46.39
-5.82
-15.36
-6.41
-92.01
-2.66
-4.96
-5.19
Net Cash Inflow / Outflow
1.45
0.33
-0.24
-4.72
-52.41
56.85
1.17
-1.48
-0.02
-0.30
Opening Cash & Equivalents
1.26
0.93
1.17
5.89
58.30
2.01
0.84
2.32
2.34
2.64
Closing Cash & Equivalent
2.71
1.26
0.93
1.17
5.89
58.85
2.01
0.84
2.32
2.34

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
91.07
85.11
80.93
97.23
89.45
55.22
47.06
40.66
34.13
30.08
ROA
5.96%
4.09%
3.33%
3.42%
0.71%
6.80%
3.39%
3.88%
2.94%
3.25%
ROE
6.39%
4.36%
3.52%
3.60%
0.75%
7.08%
3.58%
4.18%
3.21%
3.71%
ROCE
6.95%
4.86%
3.82%
4.10%
0.94%
7.12%
3.91%
4.44%
3.12%
3.82%
Fixed Asset Turnover
1.44
1.04
0.84
0.52
0.30
0.34
0.68
0.80
0.58
0.35
Receivable days
40.90
50.08
55.47
67.74
56.58
55.52
57.19
67.34
59.14
103.47
Inventory Days
157.91
210.00
251.69
329.34
222.67
174.64
99.84
119.22
149.70
216.71
Payable days
156.42
180.44
162.67
299.17
252.73
120.48
74.61
55.73
40.49
60.75
Cash Conversion Cycle
42.40
79.64
144.48
97.90
26.52
109.68
82.42
130.83
168.35
259.43
Total Debt/Equity
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
63.93
93.63
187.54
252.50
48.08
324.49
207.64
261.78
169.23
221.26

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Alembic - Quarterly Results
    11th Nov 2025, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.